BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31629608)

  • 41. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
    Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
    Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression.
    Gill J; Luckenbaugh D; Charney D; Vythilingam M
    Biol Psychiatry; 2010 Dec; 68(11):999-1006. PubMed ID: 20951370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation.
    Al-Hakeim HK; Al-Rammahi DA; Al-Dujaili AH
    J Affect Disord; 2015 Aug; 182():106-14. PubMed ID: 25985379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in the immune-inflammatory profiles of unipolar and bipolar depression.
    Brunoni AR; Supasitthumrong T; Teixeira AL; Vieira EL; Gattaz WF; Benseñor IM; Lotufo PA; Lafer B; Berk M; Carvalho AF; Maes M
    J Affect Disord; 2020 Feb; 262():8-15. PubMed ID: 31693974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.
    Mao R; Zhang C; Chen J; Zhao G; Zhou R; Wang F; Xu J; Yang T; Su Y; Huang J; Wu Z; Cao L; Wang Y; Hu Y; Yuan C; Yi Z; Hong W; Wang Z; Peng D; Fang Y
    J Affect Disord; 2018 Sep; 237():65-72. PubMed ID: 29778935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder.
    Jazayeri S; Keshavarz SA; Tehrani-Doost M; Djalali M; Hosseini M; Amini H; Chamari M; Djazayery A
    Psychiatry Res; 2010 Jun; 178(1):112-5. PubMed ID: 20466437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
    Chakrabarty T; Harkness KL; McInerney SJ; Quilty LC; Milev RV; Kennedy SH; Frey BN; MacQueen GM; Müller DJ; Rotzinger S; Uher R; Lam RW
    Psychol Med; 2020 Nov; 50(15):2536-2547. PubMed ID: 31583989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physical activity and inflammation: effects on gray-matter volume and cognitive decline in aging.
    Papenberg G; Ferencz B; Mangialasche F; Mecocci P; Cecchetti R; Kalpouzos G; Fratiglioni L; Bäckman L
    Hum Brain Mapp; 2016 Oct; 37(10):3462-73. PubMed ID: 27159568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association between depressive symptoms, cognitive function, and inflammation in major depression.
    Krogh J; Benros ME; Jørgensen MB; Vesterager L; Elfving B; Nordentoft M
    Brain Behav Immun; 2014 Jan; 35():70-6. PubMed ID: 24016864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.
    Rapaport MH; Nierenberg AA; Schettler PJ; Kinkead B; Cardoos A; Walker R; Mischoulon D
    Mol Psychiatry; 2016 Jan; 21(1):71-9. PubMed ID: 25802980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study.
    Srisurapanont M; Mok YM; Yang YK; Chan HN; Della CD; Zainal NZ; Jambunathan S; Amir N; Kalita P
    J Affect Disord; 2018 May; 232():237-242. PubMed ID: 29499506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
    Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
    Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder.
    Kéri S; Szabó C; Kelemen O
    Brain Behav Immun; 2014 Aug; 40():235-43. PubMed ID: 24726793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
    Frodl T; Amico F
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():295-303. PubMed ID: 23313563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive Performance in First-Degree Relatives of Individuals With vs Without Major Depressive Disorder: A Meta-analysis.
    MacKenzie LE; Uher R; Pavlova B
    JAMA Psychiatry; 2019 Mar; 76(3):297-305. PubMed ID: 30586133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.
    Karlović D; Serretti A; Vrkić N; Martinac M; Marčinko D
    Psychiatry Res; 2012 Jun; 198(1):74-80. PubMed ID: 22386567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated inflammatory markers in women with remitted major depressive disorder and the role of early life maltreatment.
    Dittrich K; Boedeker K; Kluczniok D; Hindi Attar C; Winter SM; Roepke S; Heim C; Herpertz SC; Bermpohl F
    Brain Behav Immun; 2021 Oct; 97():219-225. PubMed ID: 34339804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences.
    Lee EE; Ancoli-Israel S; Eyler LT; Tu XM; Palmer BW; Irwin MR; Jeste DV
    Am J Geriatr Psychiatry; 2019 Jan; 27(1):21-31. PubMed ID: 30442531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive dysfunction in major depression: From assessment to novel therapies.
    Atique-Ur-Rehman H; Neill JC
    Pharmacol Ther; 2019 Oct; 202():53-71. PubMed ID: 31173838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sex differences in the association of plasma cytokines and neurocognition in first-episode major depressive disorder.
    Lan X; Wu F; Wang C; Wu K; Fang Z; Lao G; Zhang B; Ning Y; Zhou Y
    J Affect Disord; 2023 Feb; 322():258-266. PubMed ID: 36370912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.